ArticleScientific reports2019

The DOT1L inhibitor Pinometostat decreases the host-response against infections: Considerations about its use in human therapy.

Laura Marcos-Villar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.